Point72 Asia Singapore Pte. Ltd. Acquires 419 Shares of Encompass Health Co. (NYSE:EHC)

Point72 Asia Singapore Pte. Ltd. boosted its holdings in Encompass Health Co. (NYSE:EHC) by 62.0% during the third quarter, HoldingsChannel.com reports. The fund owned 1,095 shares of the company’s stock after purchasing an additional 419 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Encompass Health were worth $106,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Bellevue Group AG raised its holdings in shares of Encompass Health by 38.7% in the 3rd quarter. Bellevue Group AG now owns 19,233 shares of the company’s stock worth $1,859,000 after buying an additional 5,365 shares in the last quarter. Fred Alger Management LLC raised its stake in Encompass Health by 1.6% during the third quarter. Fred Alger Management LLC now owns 30,641 shares of the company’s stock worth $2,961,000 after acquiring an additional 479 shares in the last quarter. Townsquare Capital LLC bought a new position in shares of Encompass Health during the third quarter valued at $405,000. BNP Paribas Financial Markets boosted its stake in shares of Encompass Health by 38.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 38,397 shares of the company’s stock valued at $3,711,000 after purchasing an additional 10,591 shares in the last quarter. Finally, Hancock Whitney Corp bought a new stake in shares of Encompass Health in the 3rd quarter worth about $782,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on EHC. Truist Financial restated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. UBS Group increased their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Royal Bank of Canada lifted their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Up 0.5 %

Shares of NYSE:EHC opened at $102.87 on Friday. The company has a 50 day moving average of $98.61 and a 200-day moving average of $91.77. Encompass Health Co. has a one year low of $64.15 and a one year high of $104.55. The stock has a market cap of $10.36 billion, a price-to-earnings ratio of 24.85, a P/E/G ratio of 1.36 and a beta of 0.86. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the company posted $0.86 EPS. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, sell-side analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health’s payout ratio is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.